The Value of Ursodeoxycholic Acid and Mesenchymal Stem Cells in the Treatment of Severe COVID-19.

Microorganisms · 2024 · PMC11279161 · PMID 39065038

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

In addition, the timing of antiviral use remains controversial, as the benefits of using antivirals in the later stages of disease progression may not be significant [ 5 , 6 , 7 ].

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.